FDA authorizes Pfizer vaccine for children ages 5 to 11
“Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” said acting FDA commissioner Janet Woodcock.
Loading the front page…
“Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” said acting FDA commissioner Janet Woodcock.
On Friday, the Food and Drug Administration (FDA) has granted emergency authorization for a lower dose of the Pfizer vaccine to be administered for children ages five to 11. The pharma giant Pfizer formally submitted the request for approval of this formulation back on Oct. 7.
Janet Woodcock, the FDA's current acting commissioner, stated the following:
"As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today's authorization. Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy."
"Our comprehensive and rigorous evaluation of the data pertaining to the vaccine's safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards," Woodcock said in a statement.
According to NPR, an advisory panel of the Center for Disease Control and Prevention (CDC) has a meeting scheduled for this coming Tuesday, at which point the panel will deliberate on the FDA's findings.
Depending on the outcome of the panel's deliberations, and pending final authorization from CDC Director Rochelle Walensky, kids could possibly start receiving their first doses of the vaccine as early as the beginning of November.
Loading this lets Rumble set cookies and collect data.
View on RumbleLibby’s Desk
Commentary and must-reads from Libby’s desk, straight to your inbox.
TPM Newsletter
The Post Millennial’s top stories, delivered to your inbox.
